>
Trade Show

Meet Datwyler at
PDA APAC: Aseptic Processing of Biopharmaceuticals Conference

Datwyler's Validated Elastomers and Closures for Sterile Biopharmaceutical Fill-Finish in Asia-Pacific

Datwyler shares expertise on elastomer qualification and sterile fill-finish packaging strategies for Asia-Pacific biopharmaceutical manufacturers. 
Date November 3, 2026 – November 4, 2026
Location Sheraton Grand Incheon Hotel | Incheon, South Korea
Schedule a Meeting View Event Details
Event Overview

Supporting Aseptic Manufacturing Excellence

Visit Datwyler at PDA's Asia-Pacific Aseptic Processing of Biopharmaceuticals Conference at the Sheraton Grand Incheon Hotel — a specialized forum for biopharmaceutical manufacturers across the region navigating the complexity of sterile fill-finish manufacturing. Our team engages quality assurance, manufacturing, and regulatory professionals on best practices for container closure integrity, elastomer component qualification, and aseptic fill-finish process design under PDA technical standards and regional regulatory frameworks. Datwyler's ready-to-use, pre-sterilized component platforms reduce contamination risk, simplify process validation, and support the documentation requirements that global regulatory approvals demand.

Solutions Spotlight

What We're Showcasing at PDA APAC: Aseptic Processing of Biopharmaceuticals Conference

Explore the solutions and technologies most relevant to this event.

Ready-to-Use Components for Aseptic Manufacturing
Featured Solution

Ready-to-Use Components for Aseptic Manufacturing

Datwyler highlights its portfolio of ready-to-use (RTU) components — pre-washed, pre-sterilized, and packaged for direct use in aseptic fill-finish operations — supporting biopharma manufacturers in achieving the highest standards of contamination control, operational efficiency, and regulatory compliance.
High-Performance Components for Biologic Drug Delivery
Featured Solution

High-Performance Components for Biologic Drug Delivery

Biologic therapies demand packaging components that deliver exceptional purity, compatibility, and performance. Datwyler's NeoFlex™ and OmniFlex® elastomer platforms are engineered to support sensitive biologic formulations, with ultra-clean manufacturing, optimized extractables profiles, and the reliability required for complex injectable drug products.
Container Closure Expertise for Asia-Pacific Pharmaceutical Manufacturers
Featured Solution

Container Closure Expertise for Asia-Pacific Pharmaceutical Manufacturers

Datwyler engages Asia-Pacific pharmaceutical manufacturers on container closure system selection, elastomer performance, and drug delivery component innovation — sharing expertise tailored to the regulatory frameworks and market dynamics shaping injectable and biologic drug production across the region.
Additional Information

Continue Exploring

Access additional materials and information related to this event and Datwyler’s solutions.

Resource On-Demand Webinar: A Quality-by-Design Approach to Annex 1 and Parenteral Packaging Manufacturing
→
Resource White Paper: EU GMP Annex 1 and Parenteral Packaging: A Quality by Design Approach
→
Resource Brochure: Solutions for Packaging and Sterilization
→
EVENT UPDATES

Stay informed on upcoming Datwyler events

Subscribe to receive updates on conferences, presentations, and opportunities to connect with our team.